Search research articles
Contact Us
Filters
Showing results (451-460 of 546) with videos related to
Page
of 55
Sort By:
European Radiology
|
March 25, 2023
Validation of the SSTR-RADS 1.0 for the structured interpretation of SSTR-PET/CT and treatment planning in neuroendocrine tumor (NET) patients
Freba Grawe, Ricarda Ebner, Thomas Geyer, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
January 18, 2024
[<sup>68 </sup>Ga]Ga-FAPI-46 PET/CT for locoregional lymph node staging in urothelial carcinoma of the bladder prior to cystectomy: initial experiences from a pilot analysis
Lena M Unterrainer, Lennert Eismann, Simon Lindner, et al.
Neuroimage
|
January 1, 2021
Microglial activation in the right amygdala-entorhinal-hippocampal complex is associated with preserved spatial learning in App<sup>NL-G-F</sup> mice
Gloria Biechele, Karin Wind, Tanja Blume, et al.
Translational Lung Cancer Research
|
August 12, 2022
Prospective evaluation of immunological, molecular-genetic, image-based and microbial analyses to characterize tumor response and control in patients with unresectable stage III NSCLC treated with concurrent chemoradiotherapy followed by consolidation therapy with durvalumab (PRECISION): protocol for a prospective longitudinal biomarker study
Lukas Käsmann, Julian Taugner, Chukwuka Eze, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 13, 2021
Toward a Universal Readout for <sup>18</sup>F-Labeled Amyloid Tracers: The CAPTAINs Study
Gérard N Bischof, Peter Bartenstein, Henryk Barthel, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
September 22, 2017
Additive value of amyloid-PET in routine cases of clinical dementia work-up after FDG-PET
Matthias Brendel, Jonas Schnabel, Sonja Schönecker, et al.
Frontiers in Oncology
|
July 8, 2021
Patient-Reported and Oncological Outcomes of Salvage Therapies for PSMA-Positive Nodal Recurrent Prostate Cancer: Real-Life Experiences and Implications for Future Trial Design
Alexander Kretschmer, Johanna Milow, Chukwuka Eze, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 2, 2023
An Analysis of the Distribution of PSMA PET/CT-Positive Lymph Nodes and Their Coverage by Different Elective Nodal Radiation Volumes in Postoperative Prostate Cancer Patients
Christian Trapp, Dmytro Oliinyk, Paul Rogowski, et al.
Theranostics
|
October 21, 2024
PET imaging of microglia in Alzheimer's disease using copper-64 labeled TREM2 antibodies
Monireh Shojaei, Rebecca Schaefer, Kai Schlepckow, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
July 10, 2023
Is PSMA PET/CT cost-effective for the primary staging in prostate cancer? First results for European countries and the USA based on the proPSMA trial
Adrien Holzgreve, Marcus Unterrainer, Jérémie Calais, et al.
Page
of 55
Search research articles
Search
Showing results (451-460 of 546) with videos related to
Sort By:
Page
of 55
European Radiology
|
March 25, 2023
Validation of the SSTR-RADS 1.0 for the structured interpretation of SSTR-PET/CT and treatment planning in neuroendocrine tumor (NET) patients
Freba Grawe, Ricarda Ebner, Thomas Geyer, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
January 18, 2024
[<sup>68 </sup>Ga]Ga-FAPI-46 PET/CT for locoregional lymph node staging in urothelial carcinoma of the bladder prior to cystectomy: initial experiences from a pilot analysis
Lena M Unterrainer, Lennert Eismann, Simon Lindner, et al.
Neuroimage
|
January 1, 2021
Microglial activation in the right amygdala-entorhinal-hippocampal complex is associated with preserved spatial learning in App<sup>NL-G-F</sup> mice
Gloria Biechele, Karin Wind, Tanja Blume, et al.
Translational Lung Cancer Research
|
August 12, 2022
Prospective evaluation of immunological, molecular-genetic, image-based and microbial analyses to characterize tumor response and control in patients with unresectable stage III NSCLC treated with concurrent chemoradiotherapy followed by consolidation therapy with durvalumab (PRECISION): protocol for a prospective longitudinal biomarker study
Lukas Käsmann, Julian Taugner, Chukwuka Eze, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 13, 2021
Toward a Universal Readout for <sup>18</sup>F-Labeled Amyloid Tracers: The CAPTAINs Study
Gérard N Bischof, Peter Bartenstein, Henryk Barthel, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
September 22, 2017
Additive value of amyloid-PET in routine cases of clinical dementia work-up after FDG-PET
Matthias Brendel, Jonas Schnabel, Sonja Schönecker, et al.
Frontiers in Oncology
|
July 8, 2021
Patient-Reported and Oncological Outcomes of Salvage Therapies for PSMA-Positive Nodal Recurrent Prostate Cancer: Real-Life Experiences and Implications for Future Trial Design
Alexander Kretschmer, Johanna Milow, Chukwuka Eze, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 2, 2023
An Analysis of the Distribution of PSMA PET/CT-Positive Lymph Nodes and Their Coverage by Different Elective Nodal Radiation Volumes in Postoperative Prostate Cancer Patients
Christian Trapp, Dmytro Oliinyk, Paul Rogowski, et al.
Theranostics
|
October 21, 2024
PET imaging of microglia in Alzheimer's disease using copper-64 labeled TREM2 antibodies
Monireh Shojaei, Rebecca Schaefer, Kai Schlepckow, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
July 10, 2023
Is PSMA PET/CT cost-effective for the primary staging in prostate cancer? First results for European countries and the USA based on the proPSMA trial
Adrien Holzgreve, Marcus Unterrainer, Jérémie Calais, et al.
Page
of 55